A Single Dose Escalation Study of HHT201 in Healthy Subjects

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions

Alzheimer Disease

Interventions

DRUG

Donepezil Dihydroxynaphthalate for Injection

HHT201 will be injected into the muscle of gluteus.

Trial Locations (1)

Zhejiang Province Taizhou Hospital Luqiao Hospital (Enze Hospital) (Taizhou Hospital Phase I Center), Taizhou

All Listed Sponsors

lead

Shanghai Synergy Pharmaceutical Sciences Co., Ltd.

INDUSTRY

NCT06373094 - A Single Dose Escalation Study of HHT201 in Healthy Subjects | Biotech Hunter | Biotech Hunter